ArticleThe Journal of clinical investigation2001

Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

L Z He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.